Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Aug 31, 2022 | |
---|---|
Total revenue | 1.83B |
Cost of revenue | 797.18M |
Gross profit | 1.03B |
Operating expense | 979.55M |
Operating profit | 53.85M |
Net non-operating interest income (expenses) | -9.56M |
Non-operating interest income | --209K |
Non-operating interest expense | --9.77M |
Net investment income | |
Gain(Loss) on financial instruments designated as cash flow hedges | |
Gain(Loss) on derecognition of available-for-sale financial assets | -20.2M |
Income from associates and other participating interests | |
Special income (charges) | -52.87M |
Less:Other special charges | --52.87M |
Other non-operating income (expenses) | 1.25M |
Income before tax | -27.52M |
Income tax | -24.49M |
Net income | -3.03M |
Net income continuous operations | ---3.03M |
Noncontrolling interests | |
Net income attributable to the company | -3.03M |
Preferred stock dividends | |
Other under preferred stock dividend | 0 |
Net income attributable to common stockholders | -3.03M |
Gross dividend payment | |
Basic earnings per share | -1.1236 |
Diluted earnings per share | -1.1236 |
Dividend per share | |
Currency Unit | JPY |
Accounting Standards | NonUS-GAAP |